Allopurinol and febuxostat were found to be associated with a higher risk of hypersensitivity reactions when compared to colchicine, according to the results of a recently published population-based study.
Several treatments were attempted but failed to manage the patient’s conditions, including proton pump inhibitors, topical steroids, a restricted diet, and infliximab (3 doses) for arthritis.
A recently published report presented at the 2019 AIBD Annual Meeting in Orlando, FL, discussed the case of a patient who developed ulcerative colitis (UC) following treatment with Secukinumab for her psoriatic arthritis and highlighted a novel approach for the management of both of her conditions simultaneously.
Compared with intravenous hydrocortisone, IV methylprednisolone appears to be more beneficial as a pre-infusion prophylaxis therapy in patients receiving pegloticase, according to the findings of a recently published review.
According to the findings of a recent review, the Food and Drug Administration rarely disagrees with recommendations made by its advisory committees.
Opioids are commonly prescribed for acute gout management following discharge from the emergency department.
“Migratory polyarthritis secondary to clopidogrel is a diagnosis of exclusion,” the study authors concluded, adding, “Early diagnosis and timely intervention are essential, as the symptoms completely resolve after discontinuing clopidogrel, and the inflammatory markers return to baseline.”
Immune modulators have proven to be effective for rheumatologic diseases by altering the immune system, however, they have also been found to produce a variety of endocrine effects in patients as well.
